OrthoPediatrics Corp. Common Stock (KIDS) is a publicly traded Healthcare sector company. As of May 21, 2026, KIDS trades at $18.16 with a market cap of $465.93M and a P/E ratio of -10.83. KIDS moved +0.00% today. Year to date, KIDS is +1.82%; over the trailing twelve months it is -19.18%. Its 52-week range spans $14.42 to $32.00. Analyst consensus is strong buy with an average price target of $24.63. Rallies surfaces KIDS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
OrthoPediatrics Q1 Revenue Up 13% to $59.4M, Guidance Raised to $263–$267M: OrthoPediatrics posted Q1 revenue of $59.4M, up 13% year-over-year, with domestic sales up 11% and international up 22%, and achieved adjusted EBITDA of $2.2M versus a $0.4M loss last year. It cut free cash flow usage by 40% and raised full-year revenue guidance to $263M–$267M.
| Metric | Value |
|---|---|
| Price | $18.16 |
| Market Cap | $465.93M |
| P/E Ratio | -10.83 |
| EPS | $-1.69 |
| Dividend Yield | 0.00% |
| 52-Week High | $32.00 |
| 52-Week Low | $14.42 |
| Volume | 1.88K |
| Avg Volume | 0 |
| Revenue (TTM) | $236.35M |
| Net Income | $-39.65M |
| Gross Margin | 73.05% |
8 analysts cover KIDS: 0 strong buy, 7 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $24.63.